Optometrist · Allentown, PA
NPI
1245589092
Since 2012
Specialty
Optometrist
Code 152W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1251 S Cedar Crest Blvd, Suite 307
Allentown, PA, 18103
Phone (610) 820-6320
Groups this clinician bills Medicare through
Medicare paid, 2024
$281K
2,078 services
Medicare patients, 2024
637
Average age 75
Drug cost, 2024
$1.6M
1,187 prescriptions
Company payments, 2025
$59K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie M McLaughlin was code 99213 (office e&m - established), 963 times for 492 patients. In total Julie M McLaughlin billed 2,078 services in 18 codes, and Medicare paid $281K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 963 | 492 | $61.79 | $60K |
| 99214 Office E&M - Established | Office | 347 | 265 | $87.85 | $30K |
| 65778 Eye | Office | 203 | 113 | $787.27 | $160K |
| 92285 Standard X-ray | Office | 170 | 162 | $15.88 | $2,699 |
| 92014 Ophthalmological E&M | Office | 94 | 93 | $82.17 | $7,724 |
| 68761 Eye | Office | 77 | 67 | $144.15 | $11K |
| 92133 Computerized Ophthalmic Imaging | Office | 54 | 51 | $23.50 | $1,269 |
| 99204 Office E&M - New | Office | 44 | 44 | $112.21 | $4,937 |
| 92083 Vision, Hearing, and Speech Services | Office | 38 | 37 | $37.20 | $1,413 |
| 92250 Angiography | Office | 28 | 28 | $21.45 | $601 |
| 92134 Computerized Ophthalmic Imaging | Office | 20 | 19 | $25.48 | $510 |
By year: 2022 $262K for 2,882 services; 2023 $285K for 2,935 services; 2024 $281K for 2,078 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 904 | 330 | $22.03 | $20K |
Medicare prescription drug claims, 2024
In 2024, the drug Julie M McLaughlin prescribed most often to Medicare patients was Xdemvy (Lotilaner), with 145 prescriptions and refills. In total Julie M McLaughlin wrote 1,187 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xdemvy Lotilaner | 145 | 203 | 136 | $265K |
| Cequa Cyclosporine | 125 | 171 | 52 | $93K |
| Miebo Perfluorohexyloctane/Pf | 123 | 167 | 41 | $119K |
| Flarex Fluorometholone Acetate | 101 | 109 | 61 | $13K |
| Restasis Cyclosporine | 89 | 181 | 42 | $108K |
| Latanoprost Generic | 78 | 187 | 21 | $1,170 |
| Cyclosporine Generic | 62 | 155 | 35 | $49K |
| Xiidra Lifitegrast | 52 | 110 | 19 | $73K |
| Lumigan Bimatoprost | 47 | 82 | 12 | $21K |
| Brimonidine Tartrate Generic | 38 | 65 | 11 | $1,542 |
| Prednisolone Acetate Generic | 35 | 62 | 18 | $1,604 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 28 | 28 | 22 | $305 |
| Timolol Maleate Generic | 22 | 65 | Under 11 | $333 |
| Tobradex St Tobramycin/Dexamethasone | 22 | 22 | 16 | $5,765 |
| Fluorometholone Generic | 21 | 23 | 13 | $1,245 |
Brand drugs: 898 claims; generic drugs: 289 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie M McLaughlin $59K ($59K in general payments such as food, travel and fees) from 9 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 40 | $21K |
| Lumenis BE inc | 1 | $20K |
| Biotissue Holdings Inc. | 17 | $13K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 12 | $4,657 |
| Abbvie Inc. ABBV | 3 | $73.54 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $52.54 |
| Harrow Eye, LLC | 2 | $50.07 |
| Alcon Vision LLC ALC | 1 | $28.07 |
| Oyster Point Pharma, Inc. | 1 | $26.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.